REGENERON PHARMACEUTICALS, INC. Accounts Receivable, Related Parties, Current
REGENERON PHARMACEUTICALS, INC. (REGN) had Accounts Receivable, Related Parties, Current of $460.80 million as of 2020-09-30, per its 10-Q filed 2020-11-05.
Discontinued › Notes
us-gaap:AccountsReceivableRelatedPartiesCurrent · last filed 2020-11-05
- 2020-09-30: Accounts Receivable, Related Parties, Current $460.80M.
- 2020-06-30: Accounts Receivable, Related Parties, Current $389.20M.
- 2020-03-31: Accounts Receivable, Related Parties, Current $468.30M.
- 2019-12-31: Accounts Receivable, Related Parties, Current $260.60M.
| Period end | Accounts Receivable, Related Parties, Current | Accounts Receivable, Related Parties, Current as first filed |
|---|---|---|
| 2020-09-30 | $460.80M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $389.20M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $468.30M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $260.60M 10-Q · filed 2020-11-05 | |
| 2019-09-30 | $345.40M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $252.00M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $287.60M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $226.40M 10-K · filed 2020-02-07 | |
| 2018-09-30 | $269.27M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $243.24M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $168.85M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $193.70M 10-K · filed 2019-02-07 | $193.68M 10-K · filed 2018-02-08 |
| 2017-09-30 | $217.48M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $221.08M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $214.27M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $92.99M 10-K · filed 2018-02-08 | |
| 2016-09-30 | $124.11M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $138.07M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $173.78M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $153.15M 10-K · filed 2017-02-09 | |
| 2015-09-30 | $199.12M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $197.69M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $159.44M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $111.51M 10-K · filed 2016-02-11 | $121.06M 10-K · filed 2015-02-12 |
| 2014-09-30 | $110.72M 10-Q · filed 2014-11-04 | |
| 2014-06-30 | $116.86M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $118.00M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $104.71M 10-K · filed 2015-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |